Abstract
Background: Fetuses exposed to maternal autoimmune diseases, such as Lupus or Sjogren's syndrome, are at risk of developing autoimmune-mediated heart block. Maternal anti-Ro/SSA or anti-La/SSB antibodies produced cross the human placenta and cause inflammation, cell death, and scaring of the fetal cardiac conduction system. The risk of mortality to the exposed fetus has been reported to be at least 18%. We were interested in detailing the outcomes and associated prenatal …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
